OPHTHALMOLOGY specialist firm Allergan Australia has announced a $300,000 platinum sponsorship deal for Glaucoma Australia, with the three year partnership focusing on early detection and treatment adherence to prevent irreversible blindness.
Allergan's contribution aims to provide education and support services to patients as well as improve early detection and referral rates and for people at risk.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 18
